Keywords: positive, data, trials, medimmune, flumist, drugmaker, says

Positive data from trials of MedImmune's FluMist

Article | 02 April 2007

Print This

US drugmaker MedImmune says that data from three key studies of its nasal influenza vaccine FluMist (live influenza vaccine) demonstrate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in